LOS ANGELES, California, September 5 /PRNewswire/ --
- Exchange: OTCBB
Immureboost Inc. announced on September 5th 2008 a name change to Fountain Healthy Aging Inc.
Fountain Healthy Aging Inc. said this approval follows the earlier approval of the name change by the Board of Directors and the Shareholders of the Company.
CEO, Dr Tony Jimenez said a name change "was appropriate as we have a new direction and a completely new business plan "
Dr Jimenez went on to say that; "Fountain Healthy Aging Inc. will be a pioneer in the anti- aging industry with our new flagship product Vitalife. Vitalife is the world's first and only transdermal growth hormone releasing hormone (GHRH) analog. Studies show statistically significant increases in hGH levels from baseline, after treatment with Vitalife."
Currently the Anti-aging industry is a US$30 Billion market. We estimate that this industry will grow by US$12 Billion in the next year and a half alone, and to US$70 Billion in the next 3 years. The worldwide global anti aging market is expected to reach US$115.5 Billion by 2010, and is now one of the fastest growing business segments in the world.
In the next few months, Fountain Healthy Aging, will focus on transitioning Vitalife into the mass market. Our existing clinical data will be bolstered by 5 additional clinical trials conducted in countries around the world that will provide further evidence of the product's safety and efficacy.
About Fountain Healthy Aging
Fountain Healthy Aging is a company specifically focussed in the anti aging industry, which is one of the quickest growing industry sectors worldwide. We have a range of products targeted at the anti aging market, including our revolutionary flagship product Vitalife, which we believe is ready to make a massive impact in the anti-aging industry. We recognize the importance of the anti-aging sector, an emerging dynamic within the overall health and wellness revolution. We believe that we are uniquely positioned to capitalize on this rapidly growing trend first with our unique flagship product, rapidly followed into the market by our other products which have been specifically developed for this market. Fountain Healthy Aging's main focus is on the specialty, premium product category, which is a growing segment of the market that provides gross margins significantly higher that the lower-priced, mainstream health products market.
The statements in the press release that relate to the company's
expectations with regard to the future impact on the company's results from
new products or actions in development are forward-looking statements,
within the meaning of the Private Securities Litigation Reform Act of 1995.
The statements in this document may also contain "forward-looking
statements" within the meaning of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934. Since this
information may contain statements that involve risk and uncertainties and
are subject to change at any time, the company's actual results may differ
materially from expected results.
For more information please contact:
Blue Chip IR, Investor Relations
|SOURCE Fountain Healthy Aging Inc|
Copyright©2008 PR Newswire.
All rights reserved